Iskanje po katalogu digitalne knjižnice

Opis: Novel bioactive bacterial nanocellulose (BnC) membranes were developed for effective, non-surgical debridement and infection-prevention in burn wound healing. Membranes were modified in situ with carboxymethyl cellulose (CMC) and ex situ with the proteolytic enzyme bromelain (Br) and antimicrobial peptide nisin (N). Post-processing into stable cellulose nanocrystal dispersions (ζ = -26 mV), enables assembly of model films for demonstration of high, irreversible bromelain (95 %) and nisin (99.5 %) adsorption. The BnC-CMC and BnC-CMC-N membranes were in vitro cytocompatible for HaCaT cells and induced faster cell proliferation with cell viability exceeding 100 % after 24 h incubation. The innovative aspect of this study lies in the ex vivo evaluation using an advanced human skin explant model with induced burns, providing a realistic, physiologically relevant assessment of membrane performance. Ex vivo experiments indicated the cytocompatibility of the BnC-CMC membrane with no acute toxicity or skin irritation, while nisin presence resulted in moderate irritating effect. Notably, the BnC-CMC-Br membrane showed digestion of intercellular junctions in the epidermis, while not inducing acute toxicity and skin irritation. By leveraging this innovative ex vivo human skin model in novel BnC-based membranes testing, the study provides a crucial translational step, bridging in vitro assessments and clinical applications for burn wound treatment.
Ključne besede: bacterial nanocellulose, Bromelain, Nisin, Carboxymethyl cellulose, antimicrobial function, bioactive, burn wound treatment
Objavljeno v DKUM: 01.04.2025; Ogledov: 0; Prenosov: 6
Celotno besedilo (24,82 MB)
Gradivo ima več datotek! Več...

Opis: The presented study assesses the efficiency of selected adsorbents, zeolite 4A in two particle sizes and pelletized activated carbon (AC), for the potential removal of color, chemical oxygen demand (COD), total organic carbon (TOC) and metals from wastewaters after natural wool dyeing. Firstly, the natural coloring compounds were extracted from dried common walnut (Juglans regia) leaves and used further for exhaustion dyeing of wool fibers, together with three different metallic salts in two concentrations (meta-mordanting). Effluents with higher mordant concentration were additionally treated according to a shake-flask adsorption experiment. The obtained results revealed efficient removal of exceeded metallic ions by zeolite (up to 94.7%), on account of their superior ion exchange capability as compared to AC. The zeolites also reduced turbidity and electrical conductivity significantly. On the other hand, AC was more efficient for the reduction in organic pollution, COD up to 96% and TOC up to 95%, due to its higher specific surface area and total pore volume, and, thus, higher potential for adsorption of different compounds in comparison to 4A. All three proposed adsorbents lowered wastewaters’ coloration remarkably, up to 78% (AC) and up to 71% (4A), depending on the type of effluent/mordant and inspected wavelength; although, the spectral absorbance coefficient (SAC) values remained highly above the limit values for discharge of wastewaters into watercourses.
Ključne besede: wool dyeing, natural dyes, wastewater treatment, decoloration, heavy metals’ reduction, adsorption
Objavljeno v DKUM: 20.03.2025; Ogledov: 0; Prenosov: 3
Celotno besedilo (27,10 MB)
Gradivo ima več datotek! Več...

Opis: Background: Two prospective randomized studies analysing cutaneous melanoma (CM) patients with sentinel lymph node (SLN) metastases and rapid development of systemic adjuvant therapy have changed our approach to stage III CM treatment. The aim of this study was to compare results of retrospective survival analysis of stage III CM patients% treatment from Slovenian national CM register to leading international clinical guidelines. Patients and methods: Since 2000, all Slovenian CM patients with primary tumour % TIb are treated at the Institute of Oncology Ljubljana and data are prospectively collected into a national CM registry. A retrospective analysis of 2426 sentinel lymph node (SLN) biopsies and 789 lymphadenectomies performed until 2015 was conducted using Kaplan-Meier survival curves and log-rank tests. Results: Positive SLN was found in 519/2426 (21.4%) of patients and completion dissection (CLND) was performed in 455 patients. The 5-year overall survival (OS) of CLND group was 58% vs. 47% of metachronous metastases group (MLNM) (p = 0.003). The 5-year OS of patients with lymph node (LN) metastases and unknown primary site (UPM) was 45% vs. 21% of patients with synchronous LN metastasis. Patients with SLN tumour burden < 0.3 mm had 5-year OS similar to SLN negative patients (86% vs. 85%; p = 0.926). The 5-year OS of patients with burden > 1.0 mm was similar to the MLNM group (49% vs. 47%; p = 0.280). Conclusions: Stage III melanoma patients is a heterogeneous group with significant OS differences. CLND after positive SLNB might still remain a method of treatment for selected patients with stage III.
Ključne besede: cutaneous melanoma, surgery treatment, sentinel node biopsy, completion lymph node dissection, overall surviva
Objavljeno v DKUM: 08.10.2024; Ogledov: 0; Prenosov: 2
Celotno besedilo (412,50 KB)
Gradivo ima več datotek! Več...

Opis: In heart failure (HF), acute decompensation can occur quickly and unexpectedly because of worsening of chronic HF or to new-onset HF diagnosed for the first time ('de novo'). Patients presenting with acute HF (AHF) have a poor prognosis comparable with those with acute myocardial infarction, and any delay of treatment initiation is associated with worse outcomes. Recent HF guidelines and recommendations have highlighted the importance of a timely diagnosis and immediate treatment for patients presenting with AHF to decrease disease progression and improve prognosis. However, based on the available data, there is still uncertainty regarding the optimal 'time-to-treatment' effect in AHF. Furthermore, the immediate post-worsening HF period plays an important role in clinical outcomes in HF patients after hospitalization and is known as the 'vulnerable phase' characterized by high risk of readmission and early death. Early and intensive treatment for HF patients in the 'vulnerable phase' might be associated with lower rates of early readmission and mortality. Additionally, in the chronic stable HF outpatient, treatments are often delayed or not initiated when symptoms are stable, ignoring the risk for adverse outcomes such as sudden death. Consequently, there is a dire need to better identify HF patients during hospitalization and after discharge and treating them adequately to improve their prognosis. HF is an urgent clinical scenario along all its stages and disease conditions. Therefore, time plays a significant role throughout the entire patient's journey. Therapy should be optimized as soon as possible, because this is beneficial regardless of severity or duration of HF. Time lavished before treatment initiation is recognized as important modifiable risk factor in HF.
Ključne besede: heart failure, prognosis, treatment
Objavljeno v DKUM: 05.08.2024; Ogledov: 99; Prenosov: 9
Celotno besedilo (5,64 MB)
Gradivo ima več datotek! Več...

Opis: Clinical pharmacy as an area of practice, education and research started developing around the 1960s when pharmacists across the globe gradually identified the need to focus more on ensuring the appropriate use of medicines to improve patient outcomes rather than being engaged in manufacturing and supply. Since that time numerous studies have shown the positive impact of clinical pharmacy services (CPS). The need for wider adoption of CPS worldwide becomes urgent, as the global population ages, and the prevalence of polypharmacy as well as shortage of healthcare professionals is rising. At the same time, there is great pressure to provide both high-quality and cost-effective health services. All these challenges urgently require the adoption of a new paradigm of healthcare system architecture. One of the most appropriate answers to these challenges is to increase the utilization of the potential of highly educated and skilled professionals widely available in these countries, i.e., pharmacists, who are well positioned to prevent and manage drug-related problems together with ensuring safe and effective use of medications with further care relating to medication adherence. Unfortunately, CPS are still underdeveloped and underutilized in some parts of Europe, namely, in most of the Central and Eastern European (CEE) countries. This paper reviews current situation of CPS development in CEE countries and the prospects for the future of CPS in that region.
Ključne besede: clinical pharmacy, cost-effective treatment, drug safety, drug utilization, health policy, medication adherence, medication errors, polypharmacy
Objavljeno v DKUM: 27.05.2024; Ogledov: 190; Prenosov: 15
Celotno besedilo (828,13 KB)
Gradivo ima več datotek! Več...